Pune, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research is a leading market research company that has published a report on the "Alzheimer’s Therapeutics Market”. The report includes key business insights, demand analysis, pricing analysis, competitive landscape, and benchmarking of key market players. Alzheimer’s Therapeutics Market size was valued at USD 4.5 Billion in 2021 and is expected to grow by 19.3 percent from 2022 to 2029, reaching nearly USD 18.46 Billion.
Alzheimer’s Therapeutics Market Scope and Research Methodology
The market research report on Alzheimer's therapeutics covers product classification, product application, development trends, product technology, competitive landscape, industrial chain structure, industry overview, national policy, and planning analysis of the industry, most recent dynamic analysis, etc. The study details the market's drivers, opportunities, and restraints. It discusses how these factors' drivers, trends, and restraints will affect market demand during the forecast period. The paper also identifies market opportunities on the global level.
The report focuses on the key manufacturers to analyze their capacity, production, value, market share, and future development plans. It also includes detailed company profiles that cover their product offerings, significant financial data, recent developments, SWOT analysis, and business strategies. Both primary and secondary data sources are extensively used in the research paper.
Get a Sample PDF Brochure:
https://www.maximizemarketresearch.com/request-sample/164747
Alzheimer’s Therapeutics Market Overview
Alzheimer's disease (AD) is a neurological ailment that affects the brain's neurons and causes memory loss, difficulty thinking and language, and aberrant behavior. Even though the number of people with Alzheimer's disease is rising quickly, just one in every four of these people receives a diagnosis.
The key factors propelling the growth of the Alzheimer's therapeutics market are the growing use of biomarkers in Alzheimer's diagnosis and drug development, as well as the rising incidence of Alzheimer's disease globally. The World Health Organization reported in September 2021 that there are over 55 million dementia sufferers worldwide, with almost 10 million new cases being diagnosed yearly. Alzheimer's disease accounts for 60–70% of all cases of dementia, making it the most common type.
Governments and non-governmental organizations are investing heavily in the development of diagnostics and therapies for the condition as a result of the rising prevalence of Alzheimer's disease in the world, which may accelerate market growth. For instance, the Diagnostics Accelerator of the Alzheimer's Drug Discovery Foundation (ADDF) launched four new research investments in June 2021 for the development of digital biomarkers for Alzheimer's diagnosis. During the forecast period, these expenditures are anticipated to fuel market growth for Alzheimer's therapeutics.
Get a Sample PDF Brochure:
https://www.maximizemarketresearch.com/request-sample/164747
Alzheimer’s Therapeutics Market Dynamics
The rising prevalence of Alzheimer's disease (AD) has made it a serious hazard to general public health. According to the Alzheimer’s Association report Around 121,499 deaths from Alzheimer's disease were reported in the US in 2019. As a result, Alzheimer's disease is the fifth most common cause of death for adults 65 and older in the United States and the sixth most common overall. New drugs for the diagnosis and treatment of the disease are badly needed as the number of people with Alzheimer's disease and mortality linked to the condition rises.
The rising number of disease drugs in the early stages of trial suggests that the industry is more focused on developing a new product that, can cure the disease. However, a declining proportion of disease-modifying therapies in later phases suggests that trial failure rates are significantly higher, particularly for disease-modifying drugs.
| Market Size in 2021 | USD 4.5 Bn. |
| Market Size in 2029 | USD 18.46 Bn. |
| CAGR | 19.3 % (2022-2029) |
| Forecast Period | 2022-2029 |
| Base Year | 2021 |
| Number of Pages | 185 |
| No. of Tables | 105 |
| No. of Charts and Figures | 103 |
| Segment Covered | Therapeutics, Diagnostics, and End-user. |
| Regional Scope | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Report Coverage | Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis. |
Download the Free Sample Report at:
https://www.maximizemarketresearch.com/request-sample/164747
Alzheimer’s Therapeutics Market Key Competitors include:
• Bristol-Myers Squibb (United States)
• Lannett Inc. (United States)
• Corium Inc. (United States)
• Adamas Pharmaceuticals Inc. (United States)
• AbbVie Inc. (United States)
• Biogen Inc. (United States)
• Johnson & Johnson (United States)
• Eli Lilly and Company (United States)
• AstraZeneca PLC (United Kingdom)
• TauRx Pharmaceuticals Ltd. (United Kingdom)
• Siemens Healthineers (Germany)
• Merz Pharma (Germany)
• Hoffmann-La Roche (Switzerland)
• Novartis AG (Switzerland)
• AC Immune (Switzerland)
• H. Lundbeck A/S (Denmark)
• Daiichi Sankyo Company, Limited (Japan)
• Eisai Co. Ltd. (Japan)
• Zydus Cadila (India)
• Lupin Limited (India)
• Aurobindo Pharma Ltd. (India)
• Cipla Ltd. (India)
• Torrent pharmaceuticals ltd. (India)
• Unichem laboratories ltd. (India)
• Teva Pharmaceutical Industries Ltd. (Israel)
Key questions answered in the Alzheimer’s Therapeutics Market are:
- What is Alzheimer’s Therapeutics?
- What is the current growth rate of the Alzheimer’s Therapeutics Market?
- Who are the key players in the Alzheimer’s Therapeutics Market?
- What are the factors affecting growth in the Alzheimer’s Therapeutics Market?
- Who held the largest market share in Alzheimer’s Therapeutics Market?
- What are the opportunities for the Alzheimer’s Therapeutics Market?
- What are the strategies used by competitors in the Alzheimer’s Therapeutics Market?
- What are the growth prospects in developing countries for the Alzheimer’s Therapeutics Market?
- Which segment is expected to witness the fastest growth and why in the Alzheimer’s Therapeutics Market?
- What is the demand pattern for the Alzheimer’s Therapeutics Market?
Purchase Report:
https://www.maximizemarketresearch.com/checkout/?method=PayPal&reportId=164747&type=Single%20User
Maximize Market Research is leading information technology and telecommunication research firm, has also published the following reports:
Microbiome Therapeutics Market- The Market was valued at US$ 0.535 Bn. in 2021. Global Microbiome Therapeutics Market size is expected to grow at a CAGR of 24.95 % through the forecast period. The combination of microbes and disease states could generate various new opportunities for drug manufacturers.
Crohn’s Disease Therapeutics Market- The market size was valued at US$ 6.67 Bn in 2021 and the total revenue is expected to grow at 5.9 % from 2022 to 2029, reaching nearly US$ 10.55 Bn. The rising frequency of the disease, combined with a growth in the number of pipeline medications, is likely to drive the market.
Dementia Treatment Market-The Market was valued at US$ 13.78 Bn in 2021 and is expected to reach US$ 26.13 Bn by 2029 at an 8.32% CAGR, during a forecast period. The scope of the report includes a detailed study of global and regional markets for Dementia Treatment with the reasons given for variants in the growth of the industry in certain regions.
Central Nervous System Therapeutics Market- The market size is expected to reach US$ 182.65 Bn. by the year 2029 at a CAGR of 9.4% during the forecast period. The rising prevalence of neurological diseases is expected to drive market growth.
Nerve Repair and Regeneration Market- The market size were valued at USD 6.2 Bn. in 2021 and the total Nerve Repair & Regeneration revenue is expected to grow by 13 % from 2022 to 2029, reaching nearly USD 16.5 Bn. due to the increasing incidence of nerve injuries and the high prevalence of neurological disorders, technological advancements for nerve repair and regeneration, and an increase in healthcare expenditure by the government in the developed market with favorable policies market is expected to grow.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact us for a more detailed view at: sales@maximizemarketresearch.com
